Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Conference News Cell Therapy 2014

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

January 26, 2014

Presentation Cell Therapy 2014

Prevention of Remodeling and CHF after Acute MI: PRESERVATION-I

Presenter: Reinilde Heyrman

January 22, 2014

Presentation Cell Therapy 2014

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Presenter: Micha? Tendera

January 22, 2014

News Conference News Cell Therapy 2013

Small Heart Failure Studies Show Positive Trends for Cell Therapy

January 27, 2013

News Conference News Cell Therapy 2013

G-CSF Shows Positive Safety, Efficacy Signals After STEMI in Preliminary Studies

January 23, 2013

Presentation Cell Therapy 2013

Sitagliptin plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction

Presenter: Wolfgang-Michael Franz

January 22, 2013

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

Presentation Cell Therapy 2012

Correlation of Early Surrogate and Late Clinical Outcomes in Randomized Controlled Studies of Stem Cell Therapy for Acute MI – Implications for Endpoint Selection

Presenter: Stephen G. Ellis

January 26, 2012

Advertisement

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

Prevention of Remodeling and CHF after Acute MI: PRESERVATION-I

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Small Heart Failure Studies Show Positive Trends for Cell Therapy

G-CSF Shows Positive Safety, Efficacy Signals After STEMI in Preliminary Studies

Sitagliptin plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction

Novel Strategies Advance Cell Therapy for Cardiomyopathy

Expedited Cell Therapy After STEMI Shows Promise

Correlation of Early Surrogate and Late Clinical Outcomes in Randomized Controlled Studies of Stem Cell Therapy for Acute MI – Implications for Endpoint Selection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content